Apjohn Group
Overview
Apjohn Group, LLC is a venture capital investment firm founded in 2001. It is composed of experienced business and pharmaceutical professionals focused on accelerating the advancement of early-stage life science companies. The firm invests in and advises companies in the biopharmaceuticals, medical devices, diagnostics, and medical technologies sectors, aiming to bridge the management and financial gap between innovators and the marketplace. The group also actively forms new companies, such as Armune BioScience and ProNAi Therapeutics (now Sierra Oncology).
Portfolio Companies
1
Website
apjohngroup.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Iaso Therapeutics | Jan 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Apjohn Group based?
Apjohn Group is headquartered in Kalamazoo, Michigan, United States.
When was Apjohn Group founded?
Founding year information for Apjohn Group is not publicly available.
How many portfolio companies does Apjohn Group have?
Apjohn Group has 1 portfolio company in Caplight's dataset.
What are some companies in Apjohn Group's portfolio?
Portfolio companies visible on Caplight include Iaso Therapeutics.
What was Apjohn Group's most recent investment shown here?
Apjohn Group's most recent investment in this portfolio sample was in Iaso Therapeutics in 2023.
What sectors does Apjohn Group focus on?
Apjohn Group focuses on Healthcare & Life Sciences.
What company stages does Apjohn Group focus on?
Apjohn Group typically invests at the Early stage.
What is Apjohn Group's AUM?
Apjohn Group's assets under management are estimated between $15.0M and $15.0M.